Cite
APA Citation
Galand, C., Venkatraman, V., Marques, M., Strauss, J., Carvajal, R., Lim, M., Morin, B., Ignatovich, O., Findeis, M., Underwood, D., Dijk, M. V., Shapiro, I., Ohanjanian, L., Wijatyk, A., Wilson, N., Buell, J., Chand, D., Savitsky, D., & Tolcher, A. (n.d.). 377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects. Journal for immunotherapy of cancer, 8, A402. http://access.bl.uk/ark:/81055/vdc_100144724682.0x000004